Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GB.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.72EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.72EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HH.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HH.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.112EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.112EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.123EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.123EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.143EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.143EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.46.6.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.46.6.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.190EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.190EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.120EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.120EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AM.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AM.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AA.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AA.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.249EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.249EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AA.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AA.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.505EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.505EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.1.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.406EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.406EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.115EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used